Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FLGT - Fulgent Genetics, Inc.

IEX Last Trade
18.285
-0.095   -0.520%

Share volume: 952
Last Updated: Fri 27 Dec 2024 05:30:17 PM CET

PREVIOUS CLOSE
CHG
CHG%
$18.38
-0.09
-0.52%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.43%
1 Month
3.47%
3 Months
-11.48%
6 Months
-9.09%
1 Year
-38.85%
2 Year
-38.95%
Key data
Stock price
$18.28
P/E Ratio 
-4.18
DAY RANGE
$18.26 - $18.74
EPS 
-$5.46
52 WEEK RANGE
$17.38 - $29.91
52 WEEK CHANGE
-$37.89
MARKET CAP 
683.493 M
YIELD 
N/A
SHARES OUTSTANDING 
30.297 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/01/2024
BETA 
0.85
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$334,445
AVERAGE 30 VOLUME 
$285,033
Company detail
CEO: Ming Hsieh
Region: US
Website: fulgentgenetics.com
Employees: 1,010
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Fulgent Genetics, Inc. provides COVID-19, molecular diagnostic, and genetic testing services in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests for the detection of SARS-CoV-2.

Recent news